Literature DB >> 15325538

Understanding and preventing severe neonatal hyperbilirubinemia: is bilirubin neurotoxity really a concern in the developed world?

Michael Kaplan1, Cathy Hammerman.   

Abstract

Although rare, extreme neonatal hyperbilirubinemia and its dreaded complication, kernicterus, continue to occur. Hyperbilirubinemia develops when bilirubin production exceeds the body's capacity to excrete it, primarily by conjugation. Genetic, environmental, and racial factors affecting the equilibrium between these processes are discussed. Adjuncts to the interpretation of the serum total bilirubin concentration are suggested. Prevention and management of severe hyperbilirubinemia should be based on American Academy of Pediatrics guidelines, with individualization including earlier institution of treatment and delayed discharge from the hospital for neonates with risk factors for kernicterus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15325538     DOI: 10.1016/j.clp.2004.05.001

Source DB:  PubMed          Journal:  Clin Perinatol        ISSN: 0095-5108            Impact factor:   3.430


  6 in total

Review 1.  American Academy of Pediatrics guidelines for detecting neonatal hyperbilirubinaemia and preventing kernicterus.

Authors:  M Kaplan; C Hammerman
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-11       Impact factor: 5.747

Review 2.  Kernicterus and the molecular mechanisms of bilirubin-induced CNS injury in newborns.

Authors:  Jon F Watchko
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

3.  Profile of minocycline neuroprotection in bilirubin-induced auditory system dysfunction.

Authors:  Ann C Rice; Victoria L Chiou; Sarah B Zuckoff; Steven M Shapiro
Journal:  Brain Res       Date:  2010-11-12       Impact factor: 3.252

4.  Cross-talk between neurons and astrocytes in response to bilirubin: adverse secondary impacts.

Authors:  Ana Sofia Falcão; Rui F M Silva; Ana Rita Vaz; Cátia Gomes; Adelaide Fernandes; Andreia Barateiro; Claudio Tiribelli; Dora Brites
Journal:  Neurotox Res       Date:  2014-07       Impact factor: 3.911

5.  Prevalence and burden of illness of treated hemolytic neonatal hyperbilirubinemia in a privately insured population in the United States.

Authors:  Tzy-Chyi Yu; Chi Nguyen; Nancy Ruiz; Siting Zhou; Xian Zhang; Elaine A Böing; Hiangkiat Tan
Journal:  BMC Pediatr       Date:  2019-02-11       Impact factor: 2.125

6.  Exchange transfusion for neonatal hyperbilirubinemia: A multicenter, prospective study of Turkish Neonatal Society.

Authors:  Emel Okulu; Ömer Erdeve; Oğuz Tuncer; Sabahattin Ertuğrul; Hülya Özdemir; Nukhet Aladağ Çiftdemir; Ayşegül Zenciroğlu; Begüm Atasay
Journal:  Turk Arch Pediatr       Date:  2021-01-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.